In severe cases, gastroparesis can lead to nutritional deficiencies, unpredictable blood glucose control in people with diabetes, and significantly reduced quality of life
doi: 10.2337/dc21-2441 13 HolstJJ
Lynn Baxter, head of North America at ViiV Healthcare, called Dovatos composition an important consideration for young people who will require lifelong treatment. April 5 Product: AstraZeneca and Daiichi Sankyos Enhertu Indication: HER2-positve solid tumors AstraZeneca and Daiichi Sankyo notched another victory for Enhertu on Friday, as the antibody-drug conjugate (ADC) became the first approved tumor-agnostic HER2-directed therapy and the first ADC to win such an indication, according to its makers
They are always friendly and helpful
More interest
Were still learning. - Andrew Grimm, MD, PhD, vice-president of global clinical development for inborn errors of metabolism at Ultragenyx